NOTE TO THE FILE
SERIAL NUMBER: 88312155
DATE: 05/06/2019
NAME: jbaker
NOTE:
Searched:
Lexis/Nexis
OneLook
Wikipedia
Acronym Finder Protest evidence reviewed
Other:Checked:
Geographic significance
Surname
Translation
ID with ID/CLASS mailboxChecked list of approved Canadian attorneys and agents
Discussed file with
Attorney/Applicant via:
phone Left message with
X email Attorney/ApplicantRequested Law Library search Issued Examiner’s Amendment
for: and entered changes in TRADEUPSPRINT DO NOT PRINT Added design code in TRADEUPS
Description of the mark
Translation statement Re-imaged standard character
drawing
Negative translation statement
Consent of living individual Contacted TM MADRID ID/CLASS
about misclassified definite ID
Changed TRADEUPS to:Jordan,
The changes you have suggested for Trademark App. Nos. 88312155, 88331577, and 88332276, as detailed below are acceptable. Please let me know if there is anything else you need.
Thanks.
----Randy
Randy Berholtz, MBA/JD
Executive Vice President, Corporate
Development and General Counsel
Innovus Pharmaceuticals, Inc.
8845 Rehco Rd
San Diego, CA 92121
Office: 858-249-7873
Cell: 858-205-5091
Fax: 858249-7879
E-mail: rberholtz@innovuspharma.com
Disclaimer: This message is confidential and proprietary to Innnovus Pharmaceuticals, Inc. or to its wholly-owned subsidiary Fastrack Pharmaceuticals, Inc and Semprae Labs. If you are not the intended recipient please either destroy this e-mail immediately and don't rely on its contents or return it immediately to the person named above. Thank you.
From: Baker, Jordan <jordan.baker@USPTO.GOV>
Sent: Friday, May 3, 2019 12:21 PM
To: Randy Berholtz <rberholtz@innovuspharma.com>
Cc: Jake Siciliano <JSiciliano@innovuspharma.com>; Vincent Arendain <VArendain@innovuspharma.com>
Subject: U.S. Trademark App. Nos. 88312155, 88331577, and 88332276 - Examiner Amendments requested
Dear Mr. Berholtz,
I am the trademark examining attorney reviewing the following applications. I believe slight amendments are required as noted below. Please confirm that they changes are acceptable and I can enter them by Examiner’s Amendment and approve them for publication.
Serial No. 88312155 – SEMPRAE LABORATORIES
Disclaimer of “LABORATORIES”
Serial No. 88331577 – INNOVUS PHARMA
Disclaimer of “PHARMA”
Serial No. 88332276 - MUSCLOPAN
ID amendment in Class 5: “Topical medical solutions to treat a variety of skin and muscular conditions by improving tissue function of both intact and damaged skin, the underlying capillary bed, and associated muscular tissues; Homeopathic medications and homeopathic pharmaceuticals for use in the treatment cramps and pain in the leg, foot, arm, hands, and neck”
Kind regards,
Jordan A. Baker
Trademark Examining Attorney
Lead Attorney for Proof of Use Audit Program
U.S. Patent and Trademark Office
Law Office 124
571-272-8844